title: Leukotriene C4/D4 induces P-selectin and sialyl Lewis(x)-dependent alterations in leukocyte kinetics in vivo.
abstract: The objective of this study was to assess the effect of leukotriene C4 (LTC4) on the flux of rolling leukocytes, leukocyte rolling velocity, and leukocyte adhesion in postcapillary venules in vivo and to study the underlying molecular mechanisms involved. LTC4 (20 nmol/L) induced a rapid and significant increase in leukocyte rolling flux that was inhibitable by an anti-P-selectin antibody and soluble sialyl Lewis(x) (sLe(x)). LTC4 also induced a significant reduction in leukocyte rolling velocity, an event that was independent of P-selectin but entirely dependent on sLe(x). This LTC4-induced reduction in leukocyte rolling velocity was independent of any hemodynamic alterations. Another P-selectin effector, histamine, did not affect leukocyte rolling velocity even at > 5000 times the concentration of LTC4. Treatment with an anti-L-selectin antibody had no effect on the LTC4-induced increase in leukocyte rolling or reduction in rolling velocity. Inhibition of LTC4 bioconversion to LTD4 by pretreatment with L-serine (100 mumol/L) prevented the LTC4-induced increase in leukocyte rolling flux and the LTC4-induced reduction in leukocyte rolling velocity. A subtle, yet significant, increase in leukocyte adhesion was also observed with LTC4. Pretreatment with a platelet-activating factor receptor antagonist returned the LTC4-induced leukocyte rolling velocity to baseline levels. The addition of a very low concentration of platelet-activating factor (1 nmol/L) induced significant leukocyte adhesion in the presence of LTC4 but not histamine.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Immunology Research Group, University of Calgary, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Kanwar
authors.forename: B
authors.initials: B
authors.lastname: Johnston
authors.forename: P
authors.initials: P
authors.lastname: Kubes
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D006439:Hemodynamics; D007700:Kinetics; D007962:Leukocytes / Q000187:drug effects* / Q000502:physiology; D017997:Leukotriene C4 / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D017998:Leukotriene D4 / Q000378:metabolism / Q000494:pharmacology; D016256:Lewis X Antigen / Q000494:pharmacology*; D008297:Male; D008853:Microscopy; D009844:Oligosaccharides / Q000494:pharmacology*; D019007:P-Selectin / Q000276:immunology / Q000494:pharmacology*; D010972:Platelet Activating Factor / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012694:Serine / Q000494:pharmacology; D000080506:Sialyl Lewis X Antigen
chemical_list: D000906:Antibodies; D016256:Lewis X Antigen; D009844:Oligosaccharides; D019007:P-Selectin; D010972:Platelet Activating Factor; D000080506:Sialyl Lewis X Antigen; D017997:Leukotriene C4; D012694:Serine; D017998:Leukotriene D4